期刊文献+

甲状腺肿瘤组织中c-myc和PCNA的表达及意义 被引量:1

Diagnostic Value of C-Myc and PCNA in Thyroid Neoplasm
暂未订购
导出
摘要 目的 探讨c -myc和增殖细胞核抗原 (PCNA)在甲状腺良、恶性肿瘤组织中的表达及其诊断意义。方法 应用免疫组化法 ,检测 2 8例甲状腺腺瘤和 3 0例甲状腺癌组织中c -myc和PCNA的表达。 结果 c -myc和PCNA在腺癌组织中阳性表达率分别为 90 .0 % (2 7/3 0 )和 80 .0 % (2 4/3 0 ) ,显著高于腺瘤组织分别为 42 .9% (12 /2 8) ,5 3 .6% (15 /2 8) ,P <0 .0 5。腺瘤组织中c -myc主要表达于细胞核 ,阳性率为 83 .3 % ;而腺癌组织则多表达于细胞质 ,阳性率为 88.9%。甲状腺肿瘤中c -myc表达和PC NA表达无相关性。结论 检测c -myc、PCNA的表达有助于甲状腺肿瘤良恶性的鉴别诊断 ;甲状腺肿瘤中c Objective To study the diagnostic value of c Myc and proliferating cell nuclear antigen(PCNA)in the benign and malignant thyroid neoplasms.Methods Expressions of C Myc and PCNA were detected in 28 thyroid adenomas and 30 thyroid carcinomas by immunohistochemical method.Results The positive rate of c Myc and PCNA was significantly higher in thyroid carcinoma than those in thyroid adenoma(90.0% and 80.0% VS 42.9% and 53.6%,respectively)( P <0.05).C Myc was mainly located in nuclear of tumor cells in thyroid adenomawith a positive rate of 83.3%.,while c Myc was mainly located in cytoplasm of tumor cells in thyroid carcinoma,with a positive rate of 88.9%.No correlation was observed between c Myc and PCNA expression in thyroid neoplasm.Conclusion The detection of c My and PCNA is valuable to differentiate between benign and malignant neoplasm of thyroid gland,and there is no synergy between c Myc and PCNA expression in thyroid neoplasm.
出处 《实用癌症杂志》 2003年第2期163-165,共3页 The Practical Journal of Cancer
关键词 甲状腺肿瘤 C-MYC 增殖细胞核抗原 诊断 临床意义 Thyroid neoplasm c Myc gene Proliferative cell nuclear antigen(PCNA)
  • 相关文献

参考文献4

二级参考文献26

  • 1左连富,齐风英,刘江惠,郭建文.乳腺癌P53基因蛋白的表达与临床预后的关系[J].癌症,1995,14(4):252-255. 被引量:13
  • 2王盛乾,陈守惠,吴若华,刘思齐,杨家祥.C-erbB-2癌基因与雌激素和孕激素受体在乳腺癌中的对比研究[J].癌症,1995,14(4):249-251. 被引量:7
  • 3Kanel D,Turpeennieni-Hujanen T,Vahakangas,et al.Proliferating cell nuclear antigen but not P53 or Human papilloma-virus DNA correlates with advanced clinical stage in renal cell carcinoma[J].Histopathology,1994,25(4):339.
  • 4Penney NS,Boacrt M,Serfling V,et al.PCNA expression in cutaneous kerationous neoplasms and verruca vulgous[J].Am J Pathol,1992,14(1):140.
  • 5Carneiro F,David I,Sunkel C,et al.Immunohistochemical analysis of ras oncogene P21 product in human gastric carcinomas and their adjacent mucosa[J].Pathol Res Pract,1992,188(1):263.
  • 6Bargmann CL, Hung MC, Weinberg RA, et al. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature, 1985:319:226-230.
  • 7Maker AP, Desmedt EJ, Potter CR, et al. Neu (c-erbB-2)oncogene in breast cancer and its possible association with the risk of distant metastases. Acta Oncol, 1990:29:931:934.
  • 8Szillosi J, Balazs M, Feuerstein BG, et al. ERBB-2 (HER-2/neu) gene copy number p185 HER-2 overexpression and intratumor hetergeneity in humam breast cancer. Cancer Res, 1995:55(22): 5400-5407.
  • 9Gusterson BA,Machin LG,Cullick WJ,et al.Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer Int J Cancer,1988:42:842-845.
  • 10Soomro S,Shousha S,Talor P,et al.C-erbB-2 expression in different histological types of invasive hreast cancinoma,J Clin Pathol,1991;4:211-214.

共引文献36

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部